{"id":"https://openalex.org/W4230099199","doi":"https://doi.org/10.12688/f1000research.7217.2","title":"Machine learning models identify molecules active against the Ebola virus in vitro","display_name":"Machine learning models identify molecules active against the Ebola virus in vitro","publication_year":2016,"publication_date":"2016-01-04","ids":{"openalex":"https://openalex.org/W4230099199","doi":"https://doi.org/10.12688/f1000research.7217.2"},"language":"en","primary_location":{"id":"doi:10.12688/f1000research.7217.2","doi":"https://doi.org/10.12688/f1000research.7217.2","is_oa":true,"landing_page_url":"https://doi.org/10.12688/f1000research.7217.2","pdf_url":null,"source":{"id":"https://openalex.org/S4210239046","display_name":"F1000Research","issn_l":"2046-1402","issn":["2046-1402"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["anvur-scientific","cwts-core","doaj","jufo-1","ki-jl-1","medline","norway-1","oarl","poland-70","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320357","host_organization_name":"Faculty of 1000","host_organization_lineage":["https://openalex.org/P4310320357","https://openalex.org/P4310320547"],"host_organization_lineage_names":["Faculty of 1000","Taylor & Francis"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"F1000Research","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref","doaj"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://doi.org/10.12688/f1000research.7217.2","any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5073973321","display_name":"Sean Ekins","orcid":"https://orcid.org/0000-0002-5691-5790","observed_orcids":["https://orcid.org/0000-0002-5691-5790"]},"institutions":[{"id":"https://openalex.org/I4210147836","display_name":"Collaborative Drug Discovery (United States)","ror":"https://ror.org/04b4sq284","country_code":"US","type":"company","lineage":["https://openalex.org/I4210147836"]},{"id":"https://openalex.org/I4210148032","display_name":"Collaborations Pharmaceuticals (United States)","ror":"https://ror.org/04m718665","country_code":"US","type":"company","lineage":["https://openalex.org/I4210148032"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Sean Ekins","raw_affiliation_strings":["Collaborations Pharmaceuticals Inc, Fuquay-Varina, NC, 27526","Collaborations in Chemistry, Fuquay-Varina, NC, 27526","Collaborative Drug Discovery, Burlingame, CA, 94010"],"raw_orcid":"https://orcid.org/0000-0002-5691-5790","affiliations":[{"raw_affiliation_string":"Collaborations Pharmaceuticals Inc, Fuquay-Varina, NC, 27526","institution_ids":["https://openalex.org/I4210148032"]},{"raw_affiliation_string":"Collaborations in Chemistry, Fuquay-Varina, NC, 27526","institution_ids":[]},{"raw_affiliation_string":"Collaborative Drug Discovery, Burlingame, CA, 94010","institution_ids":["https://openalex.org/I4210147836"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5044700909","display_name":"Joel S. Freundlich","orcid":"https://orcid.org/0000-0002-3411-3455","observed_orcids":["https://orcid.org/0000-0002-3411-3455"]},"institutions":[{"id":"https://openalex.org/I4402554120","display_name":"Rutgers New Jersey Medical School","ror":"https://ror.org/014ye1258","country_code":"US","type":"education","lineage":["https://openalex.org/I102322142","https://openalex.org/I4390039302","https://openalex.org/I4402554120"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Joel S. Freundlich","raw_affiliation_strings":["Departments of Pharmacology & Physiology and Medicine, Center for Emerging and Reemerging Pathogens, UMDNJ, New Jersey Medical School, Newark, NJ, 07103"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Departments of Pharmacology & Physiology and Medicine, Center for Emerging and Reemerging Pathogens, UMDNJ, New Jersey Medical School, Newark, NJ, 07103","institution_ids":["https://openalex.org/I4402554120"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5034678376","display_name":"Alex M. Clark","orcid":"https://orcid.org/0000-0002-3395-4666","observed_orcids":["https://orcid.org/0000-0002-3395-4666"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Alex M. Clark","raw_affiliation_strings":["Molecular Materials Informatics, Inc., Montreal, 94025"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Molecular Materials Informatics, Inc., Montreal, 94025","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5031518827","display_name":"Manu Anantpadma","orcid":"https://orcid.org/0000-0001-5796-532X","observed_orcids":["https://orcid.org/0000-0001-5796-532X"]},"institutions":[{"id":"https://openalex.org/I1289525096","display_name":"Texas Biomedical Research Institute","ror":"https://ror.org/00wbskb04","country_code":"US","type":"facility","lineage":["https://openalex.org/I1289525096"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Manu Anantpadma","raw_affiliation_strings":["Texas Biomedical Research Institute, San Antonio, TX, 78227"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Texas Biomedical Research Institute, San Antonio, TX, 78227","institution_ids":["https://openalex.org/I1289525096"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5042358991","display_name":"Robert A. Davey","orcid":"https://orcid.org/0000-0001-9168-2892","observed_orcids":["https://orcid.org/0000-0001-9168-2892"]},"institutions":[{"id":"https://openalex.org/I1289525096","display_name":"Texas Biomedical Research Institute","ror":"https://ror.org/00wbskb04","country_code":"US","type":"facility","lineage":["https://openalex.org/I1289525096"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Robert A. Davey","raw_affiliation_strings":["Texas Biomedical Research Institute, San Antonio, TX, 78227"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Texas Biomedical Research Institute, San Antonio, TX, 78227","institution_ids":["https://openalex.org/I1289525096"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5025984430","display_name":"Peter B. Madrid","orcid":"https://orcid.org/0000-0002-4895-5610","observed_orcids":["https://orcid.org/0000-0002-4895-5610"]},"institutions":[{"id":"https://openalex.org/I1298353152","display_name":"SRI International","ror":"https://ror.org/05s570m15","country_code":"US","type":"nonprofit","lineage":["https://openalex.org/I1298353152"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Peter Madrid","raw_affiliation_strings":["SRI International, Menlo Park, CA, 94025"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"SRI International, Menlo Park, CA, 94025","institution_ids":["https://openalex.org/I1298353152"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":5,"corresponding_author_ids":["https://openalex.org/A5073973321"],"corresponding_institution_ids":["https://openalex.org/I4210147836","https://openalex.org/I4210148032"],"apc_list":{"value":1350,"currency":"USD","value_usd":1350},"apc_paid":{"value":1350,"currency":"USD","value_usd":1350},"fwci":3.2488,"has_fulltext":true,"cited_by_count":17,"citation_normalized_percentile":{"value":0.92570079,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":88,"max":98},"biblio":{"volume":"4","issue":null,"first_page":"1091","last_page":"1091"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10211","display_name":"Computational Drug Discovery Methods","score":0.92330002784729,"subfield":{"id":"https://openalex.org/subfields/1703","display_name":"Computational Theory and Mathematics"},"field":{"id":"https://openalex.org/fields/17","display_name":"Computer Science"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},"topics":[{"id":"https://openalex.org/T10211","display_name":"Computational Drug Discovery Methods","score":0.92330002784729,"subfield":{"id":"https://openalex.org/subfields/1703","display_name":"Computational Theory and Mathematics"},"field":{"id":"https://openalex.org/fields/17","display_name":"Computer Science"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},{"id":"https://openalex.org/T11581","display_name":"Viral Infections and Outbreaks Research","score":0.06120000034570694,"subfield":{"id":"https://openalex.org/subfields/2725","display_name":"Infectious Diseases"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12576","display_name":"vaccines and immunoinformatics approaches","score":0.00279999990016222,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/ebola-virus","display_name":"Ebola virus","score":1.0},{"id":"https://openalex.org/keywords/antiviral-drug-discovery","display_name":"antiviral drug discovery","score":0.8399999737739563},{"id":"https://openalex.org/keywords/small-molecule-inhibitors","display_name":"small molecule inhibitors","score":0.9089999794960022},{"id":"https://openalex.org/keywords/bayesian-learning","display_name":"Bayesian learning","score":0.7889999747276306},{"id":"https://openalex.org/keywords/virtual-screening","display_name":"virtual screening","score":0.7720000147819519},{"id":"https://openalex.org/keywords/quinacrine","display_name":"quinacrine","score":0.9279999732971191},{"id":"https://openalex.org/keywords/pyronaridine","display_name":"pyronaridine","score":1.0},{"id":"https://openalex.org/keywords/tilorone","display_name":"tilorone","score":0.9869999885559082},{"id":"https://openalex.org/keywords/4-aminoquinolines","display_name":"4-aminoquinolines","score":0.9100000262260437},{"id":"https://openalex.org/keywords/antimalarial-drugs","display_name":"antimalarial drugs","score":0.828000009059906},{"id":"https://openalex.org/keywords/drug-repurposing","display_name":"drug repurposing","score":0.6110000014305115}],"concepts":[{"id":"https://openalex.org/C2777469322","wikidata":"https://www.wikidata.org/wiki/Q8064876","display_name":"Ebola virus","level":3,"score":0.7574092149734497},{"id":"https://openalex.org/C74187038","wikidata":"https://www.wikidata.org/wiki/Q1418791","display_name":"Drug discovery","level":2,"score":0.492532342672348},{"id":"https://openalex.org/C70721500","wikidata":"https://www.wikidata.org/wiki/Q177005","display_name":"Computational biology","level":1,"score":0.4781644940376282},{"id":"https://openalex.org/C10679952","wikidata":"https://www.wikidata.org/wiki/Q5308937","display_name":"Druggability","level":3,"score":0.43037739396095276},{"id":"https://openalex.org/C159047783","wikidata":"https://www.wikidata.org/wiki/Q7215","display_name":"Virology","level":1,"score":0.42091104388237},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.3921722173690796},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.33716046810150146},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.32076624035835266},{"id":"https://openalex.org/C2522874641","wikidata":"https://www.wikidata.org/wiki/Q808","display_name":"Virus","level":2,"score":0.2930040955543518},{"id":"https://openalex.org/C60644358","wikidata":"https://www.wikidata.org/wiki/Q128570","display_name":"Bioinformatics","level":1,"score":0.23278436064720154},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.09609785676002502},{"id":"https://openalex.org/C104317684","wikidata":"https://www.wikidata.org/wiki/Q7187","display_name":"Gene","level":2,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.12688/f1000research.7217.2","doi":"https://doi.org/10.12688/f1000research.7217.2","is_oa":true,"landing_page_url":"https://doi.org/10.12688/f1000research.7217.2","pdf_url":null,"source":{"id":"https://openalex.org/S4210239046","display_name":"F1000Research","issn_l":"2046-1402","issn":["2046-1402"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["anvur-scientific","cwts-core","doaj","jufo-1","ki-jl-1","medline","norway-1","oarl","poland-70","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320357","host_organization_name":"Faculty of 1000","host_organization_lineage":["https://openalex.org/P4310320357","https://openalex.org/P4310320547"],"host_organization_lineage_names":["Faculty of 1000","Taylor & Francis"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"F1000Research","raw_type":"journal-article"}],"best_oa_location":{"id":"doi:10.12688/f1000research.7217.2","doi":"https://doi.org/10.12688/f1000research.7217.2","is_oa":true,"landing_page_url":"https://doi.org/10.12688/f1000research.7217.2","pdf_url":null,"source":{"id":"https://openalex.org/S4210239046","display_name":"F1000Research","issn_l":"2046-1402","issn":["2046-1402"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["anvur-scientific","cwts-core","doaj","jufo-1","ki-jl-1","medline","norway-1","oarl","poland-70","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320357","host_organization_name":"Faculty of 1000","host_organization_lineage":["https://openalex.org/P4310320357","https://openalex.org/P4310320547"],"host_organization_lineage_names":["Faculty of 1000","Taylor & Francis"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"F1000Research","raw_type":"journal-article"},"sustainable_development_goals":[{"score":0.8048999905586243,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":75,"referenced_works":["https://openalex.org/W342897826","https://openalex.org/W566203586","https://openalex.org/W821220044","https://openalex.org/W822668957","https://openalex.org/W1505662983","https://openalex.org/W1756907890","https://openalex.org/W1968135993","https://openalex.org/W1972277405","https://openalex.org/W1986101280","https://openalex.org/W1990484619","https://openalex.org/W1990919689","https://openalex.org/W1995884986","https://openalex.org/W2002345936","https://openalex.org/W2007560618","https://openalex.org/W2007705439","https://openalex.org/W2011068300","https://openalex.org/W2024737681","https://openalex.org/W2028988905","https://openalex.org/W2029772003","https://openalex.org/W2033354157","https://openalex.org/W2036802924","https://openalex.org/W2038627745","https://openalex.org/W2040135138","https://openalex.org/W2041253429","https://openalex.org/W2046613566","https://openalex.org/W2049166204","https://openalex.org/W2050157100","https://openalex.org/W2055813502","https://openalex.org/W2057543416","https://openalex.org/W2060297381","https://openalex.org/W2061650979","https://openalex.org/W2068604502","https://openalex.org/W2073726103","https://openalex.org/W2078543981","https://openalex.org/W2081585520","https://openalex.org/W2082943236","https://openalex.org/W2089968967","https://openalex.org/W2090471918","https://openalex.org/W2099499240","https://openalex.org/W2102952492","https://openalex.org/W2108978878","https://openalex.org/W2110959690","https://openalex.org/W2113035264","https://openalex.org/W2114445615","https://openalex.org/W2125852843","https://openalex.org/W2131582481","https://openalex.org/W2138289533","https://openalex.org/W2142602210","https://openalex.org/W2146117672","https://openalex.org/W2148797284","https://openalex.org/W2149743270","https://openalex.org/W2150451731","https://openalex.org/W2150837053","https://openalex.org/W2152082550","https://openalex.org/W2154183412","https://openalex.org/W2155741020","https://openalex.org/W2159486360","https://openalex.org/W2161459134","https://openalex.org/W2162126991","https://openalex.org/W2162395676","https://openalex.org/W2163576609","https://openalex.org/W2165629863","https://openalex.org/W2166753235","https://openalex.org/W2167773607","https://openalex.org/W2168447130","https://openalex.org/W2171660521","https://openalex.org/W2256071216","https://openalex.org/W2298069345","https://openalex.org/W2319721327","https://openalex.org/W2329563494","https://openalex.org/W2395664412","https://openalex.org/W2398198205","https://openalex.org/W2401677822","https://openalex.org/W4239566362","https://openalex.org/W4394549945"],"related_works":["https://openalex.org/W2741432404","https://openalex.org/W2913529882","https://openalex.org/W2957546167","https://openalex.org/W3193133460","https://openalex.org/W4294190648","https://openalex.org/W2795853169","https://openalex.org/W2779507963","https://openalex.org/W4408995769","https://openalex.org/W3045259741","https://openalex.org/W3000933520"],"abstract_inverted_index":{"The":[0],"search":[1],"for":[2,61,72,185,203],"small":[3],"molecule":[4],"inhibitors":[5,293],"of":[6,27,40,53,134,145,170,181,231,252],"Ebola":[7],"virus":[8],"(EBOV)":[9],"has":[10,226,262],"led":[11],"to":[12,69,75,128,136,140,289],"several":[13,39],"high":[14,82],"throughput":[15,83],"screens":[16],"over":[17],"the":[18,81,93,109,117,131,146,154,192,216],"past":[19],"3":[20],"years.":[21],"These":[22],"have":[23,97,115,123],"identified":[24],"a":[25,46,179,182,228],"range":[26],"FDA-approved":[28],"active":[29,44,211],"pharmaceutical":[30],"ingredients":[31],"(APIs)":[32],"with":[33,103,272],"anti-EBOV":[34,65],"activity":[35,249],"in":[36,45,153,164,238,285,294],"vitro":[37,165],"and":[38,86,108,120,160,166,173,250],"which":[41,196],"are":[42,51],"also":[43,124,261],"mouse":[47],"infection":[48],"model.":[49],"There":[50],"millions":[52],"additional":[54],"commercially-available":[55],"molecules":[56,149,276],"that":[57,150,187,225,283],"could":[58],"be":[59,141,287],"screened":[60],"potential":[62,142],"activities":[63,233],"as":[64,264],"compounds.":[66],"One":[67],"way":[68],"prioritize":[70],"compounds":[71],"testing":[73],"is":[74,178,220,257],"generate":[76],"computational":[77],"models":[78,102,118,127,282],"based":[79],"on":[80],"screening":[84],"data":[85,270],"then":[87],"virtually":[88],"screen":[89],"compound":[90],"libraries.":[91],"In":[92],"current":[94],"study,":[95],"we":[96],"generated":[98],"Bayesian":[99],"machine":[100,280],"learning":[101,281],"viral":[104],"pseudotype":[105],"entry":[106],"assay":[107,112],"EBOV":[110,292],"replication":[111],"data.":[113],"We":[114,122],"validated":[116,279],"internally":[119],"externally.":[121],"used":[125],"these":[126],"computationally":[129],"score":[130],"MicroSource":[132],"library":[133],"drugs":[135,210],"select":[137],"those":[138],"likely":[139],"inhibitors.":[143],"Three":[144],"highest":[147],"scoring":[148],"were":[151,162],"not":[152],"model":[155],"training":[156],"sets,":[157],"quinacrine,":[158],"pyronaridine":[159],"tilorone,":[161],"tested":[163],"had":[167],"EC50":[168],"values":[169],"350,":[171],"420":[172],"230":[174],"nM,":[175],"respectively.":[176],"Pyronaridine":[177],"component":[180],"combination":[183],"therapy":[184],"malaria":[186],"was":[188],"recently":[189],"approved":[190],"by":[191],"European":[193],"Medicines":[194],"Agency,":[195],"may":[197],"make":[198],"it":[199,214],"more":[200],"readily":[201],"accessible":[202],"clinical":[204],"testing.":[205],"Like":[206],"other":[207],"known":[208],"antimalarial":[209,259],"against":[212],"EBOV,":[213],"shares":[215],"4-aminoquinoline":[217],"scaffold.":[218],"Tilorone,":[219],"an":[221,258,265],"investigational":[222],"antiviral":[223],"agent":[224],"shown":[227],"broad":[229],"array":[230],"biological":[232],"including":[234],"cell":[235],"growth":[236],"inhibition":[237],"cancer":[239],"cells,":[240],"antifibrotic":[241],"properties,":[242],"\u03b17":[243],"nicotinic":[244],"receptor":[245],"agonist":[246],"activity,":[247],"radioprotective":[248],"activation":[251],"hypoxia":[253],"inducible":[254],"factor-1.":[255],"Quinacrine":[256],"but":[260],"use":[263],"anthelmintic.":[266],"Our":[267],"results":[268],"suggest":[269],"sets":[271],"less":[273],"than":[274],"1,000":[275],"can":[277,284],"produce":[278],"turn":[286],"utilized":[288],"identify":[290],"novel":[291],"vitro.":[295]},"counts_by_year":[{"year":2024,"cited_by_count":1},{"year":2022,"cited_by_count":3},{"year":2021,"cited_by_count":1},{"year":2019,"cited_by_count":3},{"year":2018,"cited_by_count":4},{"year":2017,"cited_by_count":2},{"year":2016,"cited_by_count":3}],"updated_date":"2026-11-03T10:50:19.383937","created_date":"2022-05-11T00:00:00"}